Do you want to read an article? Please log in or register.
Key learnings from the INBUILD trial in patients with progressive pulmonary fibrosis
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Effects of home-based telerehabilitation-assisted inspiratory muscle training in patients with idiopathic pulmonary fibrosis: A randomized controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respirology
Aktan R, Tertemiz KC, Yiğit S, Özalevli S, Ozgen Alpaydin A, Uçan ES
doi: 10.1111/resp.14810
Pulmonary Fibrosis
Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis
Chest
Oldham JM, Neely ML, Wojdyla DM, Gulati M, Li P, Patel DC, Palmer SM, Todd JL, Idiopathic Pulmonary Fibrosis-Prospective Outcomes Registry Investigators
doi: 10.1016/j.chest.2025.02.018
RECOMMENDED
Pulmonary Fibrosis
Effect of Admilparant, an LPA1 Antagonist, on Disease Progression in Pulmonary Fibrosis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Chest
Kreuter M, Maher TM, Wuyts WA, Valenzuela C, Hamblin M, Kim S, Patel A, Elpers B, Richeldi L
doi: 10.1016/j.chest.2025.04.003
RECOMMENDED
Pulmonary Fibrosis
Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev
Delameillieure A, Somogyi V, Schenk S, Toreyin N, Stenzel N, Van Bulck L, Breuls S, Kreuter M, Wuyts WA, Mogulkoc N, Boyd J, Jones S, Galvin L, Dobbels F, COCOS-IPF consortium
doi: 10.1183/16000617.0133-2024
RECOMMENDED
Pulmonary Fibrosis
Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National Registry
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respirology
Platenburg MGJP, Nakshbandi G, Moor CC, van Batenburg AA, Mostard RLM, Voortman M, Moonen L, Hekelaar N, Overbeek MJ, Bogaarts B, Kramer H, Marges E, Boerrigter BB, Bresser P, Schakenraad E, van der Maten J, van der Sloot CA, Walen S, Afonso PM, Wijsenbeek MS, Grutters JC
doi: 10.1111/resp.70030
Pulmonary Fibrosis
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
Lancet Respir Med
Alonso-González A, Jáspez D, Lorenzo-Salazar JM, Ma SF, Strickland E, Mychaleckyj J, Kim JS, Huang Y, Adegunsoye A, Oldham JM, Stewart I, Molyneaux PL, Maher TM, Wain LV, Allen RJ, Gisli Jenkins R, Kropski JA, Yaspan B, Blackwell TS, Zhang D, Garcia CK, Martinez FJ, Noth I, Flores C
doi: 10.1016/S2213-2600(25)00045-1
Pulmonary Fibrosis
Antifibrotic drug treatment of patients with idiopathic pulmonary fibrosis in Sweden: A registry-based observational study
Chron Respir Dis
Carlson L, Kalafatis D, Pesonen I, Magnusson JM, Skold M
doi: 10.1177/14799731241299443
Pulmonary Fibrosis
The Effects of Progressive Muscle Relaxation on Mental Health and Sleep Quality in Adults with Cystic Fibrosis: A Randomized Controlled Trial
J Clin Med
Maritescu A, Pescaru CC, Crisan AF, Stoicescu ER, Oancea C, Iacob D
doi: 10.3390/jcm14082807
RECOMMENDED
Pulmonary FibrosisFurther Publications
Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Wells AU, Walsh SLF, Adegunsoye A, Cottin V, Danoff SK, Devaraj A, Flaherty KR, George PM, Johannson KA, Kolb M, Kondoh Y, Nicholson AG, Tomassetti S, Volkmann ER, Brown KK
doi: 10.1186/s12931-024-03070-z